JPMorgan Chase & Co. (NYSE:JPM) is expanding benefits to help employees pay for fertility treatments and surrogacy services, according to an internal memo obtained by CNBC. Employees in the U.S. without a medical diagnosis of infertility can now have up to $30,000 of treatments including in vitro fertilization covered, according to the letter, which was sent to workers earlier this week. The New York-based bank also increased reimbursement for costs related to surrogacy, which involves compensating a woman to carry a child to term, to $30,000 from $10,000.
Technical Stock Analysis
JPMorgan Chase & Co. (NYSE:JPM), a Financial sector firm, traded 27.07 Million shares in last trading session and stock shed -0.68% with closing price of $109.44 per share. Company gross margins represents its total sales revenue minus its cost of goods sold (COGS), divided by the total sales revenue earned by the company, expressed as a percentage.
Investment Worthy Stock or not?
For personal guess ROI is usually expressed as a percentage and is typically used for taking any financial decisions, for the purpose of comparing a JPMorgan Chase & Co. (NYSE:JPM)’s profitability or to compare the efficiency of different investments, hence, JPM return on investment (ROI) is 8.20%.
52-Week Range are valuable stats for watching JPMorgan Chase & Co. (NYSE:JPM)’s past year fluctuation as that gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range. JPMorgan Chase & Co. (NYSE:JPM)’s stock value has moved between $91.2 – 118.96 in last one year.
Analysts mean target price for JPMorgan Chase & Co. (NYSE:JPM) is $118.84 while analysts mean recommendation is 2.30.
Its weekly performance is -0.35% while year to date (YTD) performance is 12.11%.
Earnings per share growth is defined as the percentage change in normalised earnings per share over the previous 12 month period to the latest year end. It gives a good picture of the rate at which a company has grown its profitability. JPMorgan Chase & Co. (NYSE:JPM)’s EPS growth this year is 31.50%. For best decision making investors should look at JPMorgan Chase & Co. (NYSE:JPM)’s EPS growth for next year stands at 6.18%.